EMA
Refine Search
Biotechnology
ETF recommends updating COVID-19 vaccines to target new JN.1 variant 30 April 2024
Biosimilars
EMA’s CHMP announces April 2024 recommendations for approval 27 April 2024
Biotechnology
BeiGene’s tislelizumab approved in Europe for lung cancer; 26 April 2024
Pharmaceutical
EC approves Filspari for the treatment of IgA nephropathy 24 April 2024
Biotechnology
A first-in-class treatment for paroxysmal nocturnal haemoglobinuria (PNH), Voydeya (danicopan), has been granted marketing authorization in Europe. 23 April 2024
Pharmaceutical
EC approval for Pfizer’s Emblaveo in multidrug-resistant infections 22 April 2024
Biotechnology
Carvykti first BCMA-targeted treatment approved by EC 22 April 2024
Biotechnology
Bimzelx approved by EC as the first IL-17A and IL-17F biologic for moderate to severe HS 22 April 2024
Biosimilars
EC approval for Pyzchiva, a biosimilar of Stelara 22 April 2024
Pharmaceutical
Available evidence does not support a link between GLP-1 receptor agonists with suicidal and self-injurious thoughts and actions. 12 April 2024
Pharmaceutical
The European Parliament has formally adopted new pharmaceutical legislation, including proposals for a new directive and a new regulation. 11 April 2024
Pharmaceutical
A second Expert View piece from Xandra Neuberger, associate director, regulatory affairs and international service lead for clinical trial applications at Pharm 4 April 2024
Pharmaceutical
With new legislation on data protection in the offing, The European Federation of Pharmaceutical Industries and Associations (EFPIA) has called on negotiators t 2 April 2024
Pharmaceutical
Guidance needed to ensure EU’s JCA improves access to innovative cancer treatments 2 April 2024
Biotechnology
The week in pharma: action, reaction and insight – week to March 29, 2024 31 March 2024
Biotechnology
EMA grants PRIME status for 89bio’s pegozafermin 27 March 2024
Biosimilars
Samsung Bioepis’ Epysqli gains expanded EC approval 27 March 2024
Pharmaceutical
Danish firm Lundbeck and Japan’s Otsuka Pharmaceutical have secured European approval for a new formulation of Abilify Maintena (aripiprazole). 27 March 2024
Pharmaceutical
EMA recommendations for 2024/2025 seasonal flu vaccine composition 27 March 2024
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze